Back to School: How biopharma can reboot drug development. Access exclusive analysis here
In a 1-year, 69-patient post-marketing study, Byetta improved beta cell function by 146% compared
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury